CIO provided the optimal platform for collaboration with multidisciplinary specialties who participate in the management of oncology patients. The input from industry specialists and interventional radiologists with direct experience with their products offers a unique perspective on both FDA-approved and future therapy options. The encouragement provided to residents and fellows proves CIO remains dedicated to educating the future of IO specialists within the sphere of oncology.